IGF1 and colorectal cancer: Both insulin and IGF-1 are potent mitogens that promote colorectal cancer cell growth and survival in vitro (Komninou et al, 2003), and elevated blood levels of IGF-1 and insulin are associated with increased risk of developing colorectal cancer (Komninou et al, 2003).